South Rampart Pharma is a team of experienced clinicians, researchers, innovators and lead business management experts who recognized the immense burden placed on patients and the healthcare system from the limitations of available pain medicines—which is why we’ve set out to change the status quo.

Our small-molecule solutions have the potential to overcome many risks associated with current pain medicines, offering patients and clinicians a safer option for pain medicines. And because our molecule is not a biologic therapy, the end product should be low-cost and accessible to many patients.